Stereotactic Body Radiotherapy (SBRT)
At Mays Cancer Center, home to UT Health San Antonio MD Anderson Cancer Center, our radiation oncologists combine advanced technologies with exceptional cancer expertise.
Daruka Mahadevan, MD, PhD Hematology Oncology, Phase I Clinical Trials
Mio Kitano, MD, MPH, FACS, FSSO Surgical Oncology
Danielle Fritze, MD Liver Transplant Surgery, Liver, Pancreas and Hepatobiliary Cancer Surgery
A Phase 1 Open-Label Study to Evaluate the Efficacy and Safety of ABBV-400 in Select Advanced Solid Tumor Indications
To assess the efficacy of ABBV-400 in each solid tumor indication, including advanced or metastatic hepatocellular (HCC), biliary tract cancer (BTC), pancreatic ductal adenocarcinoma (PDAC), esophageal squamous cell carcinoma (ESCC), triple negative (TN) breast cancer (BC), hormone receptor-positive (HR+)/human epidermal growth factor receptor 2 negative (HER2-) BC, and head and neck squamous cell carcinoma (HNSCC). The purpose of this study is to evaluate ABBV-400 in subjects with select solid tumors. This study will consist of multiple cohorts with each cohort investigating ABBV-400 at 3 mg/kg Q3W.
Cancer Genetics Program
Cancer Genetics Program
Gregory Abrahamian, M.D. Liver Transplant Surgery, Liver, Pancreas and Hepatobiliary Cancer Surgery
Rare and Familial Endocrine Tumors
Rare and Familial Endocrine Tumors